XML 43 R22.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation
6 Months Ended
Jun. 30, 2012
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation
Stock-Based Compensation
 
In March 2006, the Board of Directors approved the Steven Madden, Ltd. 2006 Stock Incentive Plan (the “Plan”) under which nonqualified stock options, stock appreciation rights, performance shares, restricted stock, other stock-based awards and performance-based cash awards may be granted to employees, consultants and non-employee directors. The stockholders approved the Plan on May 26, 2006. On May 25, 2007, the stockholders approved an amendment to the Plan to increase the maximum number of shares that may be issued under the Plan from 2,700,000 to 3,487,500. On May 22, 2009, the stockholders approved a second amendment to the Plan that increased the maximum number of shares that may be issued under the Plan to 9,144,000. On May 25, 2012, the stockholders approved a third amendment to the Plan that increased the maximum number of shares that may be issued under the Plan to 15,644,000. The following table summarizes the number of shares of common stock authorized for use under the Plan, the number of stock-based awards granted (net of expired or cancelled awards) under the Plan and the number of shares of common stock available for the grant of stock-based awards under the Plan:
 
Common stock authorized
15,644,000

Stock-based awards, including restricted stock and stock options granted, net of expired or cancelled
(8,655,000
)
 
 

Common stock available for grant of stock-based awards as of June 30, 2012
6,989,000


 


 Note Q – Stock-Based Compensation (continued)

Total equity-based compensation for the three and six months ended June 30 is as follows:
 
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2012
 
2011
 
2012
 
2011
Restricted stock
$
2,407

 
$
1,420

 
$
4,858

 
$
2,608

Stock options
1,536

 
1,620

 
3,092

 
2,957

Total
$
3,943

 
$
3,040

 
$
7,950

 
$
5,565


 
Equity-based compensation is included in operating expenses on the Company’s Condensed Consolidated Statements of Income.
 
Stock Options
 
Cash proceeds and intrinsic values related to total stock options exercised during the three- and six-month periods ended June 30, 2012 and 2011 are as follows:
 
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2012
 
2011
 
2012
 
2011
Proceeds from stock options exercised
$
1,478

 
$
3,254

 
$
4,950

 
$
3,485

Intrinsic value of stock options exercised
$
2,963

 
$
7,510

 
$
8,232

 
$
7,799


 
During the three and six months ended June 30, 2012, options to purchase approximately 456,000 shares of common stock with a weighted average exercise price of $14.75 and options to purchase approximately 680,000 shares of common stock with a weighted average exercise price of $17.55 vested, respectively. During the three and six months ended June 30, 2011, options to purchase approximately 489,000 shares of common stock with a weighted average exercise price of $13.48 and options to purchase approximately 611,000 shares of common stock with a weighted average exercise price of $13.92 vested, respectively. As of June 30, 2012, there were unvested options relating to 1,348,000 shares of common stock with a total of $9,054 of unrecognized compensation cost and an average vesting period of 2.2 years.
 
The Company uses the Black-Scholes option-pricing model to estimate the fair value of options granted, which requires several assumptions. The expected term of the options represents the estimated period of time until exercise and is based on the historical experience of similar awards. Expected volatility is based on the historical volatility of the Company’s common stock. The risk free interest rate is based on the U.S. Treasury yield curve in effect at the time of the grant. With the exception of special dividends paid in November of 2005 and 2006, the Company historically has not paid regular cash dividends and thus the expected dividend rate is assumed to be zero. The following weighted average assumptions were used for stock options granted:

 
 
2012
 
2011
Volatility
 
41.1% to 47.4%
 
47.6% to 48.7%
Risk free interest rate
 
0.48% to 0.87%
 
1.22% to 1.78%
Expected life in years
 
3.1 to 4.6
 
2.8 to 4.4
Dividend yield
 
0.00%
 
0.00%
Weighted average fair value
 
$14.03
 
$10.83

 



Note Q – Stock-Based Compensation (continued)

Activity relating to stock options granted under the Company’s plans and outside the plans during the six months ended June 30, 2012 is as follows: 
 
 
Number of Shares
 
Weighted Average Exercise Price
 
Weighted Average Remaining Contractual Term
 
Aggregate Intrinsic Value
Outstanding at January 1, 2012
 
2,703,000

 
$
17.79

 
 
 
 

Granted
 
190,000

 
40.71

 
 
 
 

Exercised
 
(316,000
)
 
15.69

 
 
 
 

Cancelled/Forfeited
 
(1,000
)
 
24.71

 
 
 
 

Outstanding at June 30, 2012
 
2,576,000

 
$
19.73

 
4.5 years
 
$
33,405

Exercisable at June 30, 2012
 
1,228,000

 
$
16.49

 
4.0 years
 
$
19,328


 
Restricted Stock
 
The following table summarizes restricted stock activity during the six months ended June 30, 2012 and 2011:
 
 
 
2012
 
2011
 
 
Number of Shares
 
Weighted Average Fair Value at Grant Date
 
Number of Shares
 
Weighted Average Fair Value at Grant Date
Non-vested at January 1
 
671,000

 
$
25.44

 
563,000

 
$
17.20

Granted
 
1,140,000

 
41.13

 
323,000

 
31.16

Vested
 
(169,000
)
 
24.80

 
(179,000
)
 
14.93

Forfeited
 

 

 

 

Non-vested at June 30
 
1,642,000

 
$
36.40

 
707,000

 
$
24.15


 
As of June 30, 2012, there was $55,362 of total unrecognized compensation cost related to restricted stock awards granted under the Plan. This cost is expected to be recognized over a weighted average of 9 years. The Company determines the fair value of its restricted stock awards based on the market price of its common stock on the date of grant.
 
On January 3, 2012, the Company and its Creative and Design Chief, Steven Madden, entered into an amendment of Mr. Madden’s existing employment agreement, pursuant to which, on February 8, 2012, Mr. Madden was granted 975,371 restricted shares of the Company’s common stock at the then market price of $41.01, which will vest in equal annual installments over a seven-year period commencing on December 31, 2017 and, thereafter, on each December 31 through December 31, 2023, subject to Mr. Madden’s continued employment on each such vesting date. Pursuant to the contract, on June 30, 2012, Mr. Madden exercised his right to receive an additional restricted stock award, and on July 3, 2012 he was granted 1,262,228 restricted shares of the Company's common stock at the then market price of $31.69, which will vest in the same manner as the prior grant.